Filing Details
- Accession Number:
- 0001179110-11-003465
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-02-25 17:12:30
- Reporting Period:
- 2011-02-23
- Filing Date:
- 2011-02-25
- Accepted Time:
- 2011-02-25 17:12:30
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
820237 | Gen Probe Inc | GPRO | Surgical & Medical Instruments & Apparatus (3841) | 330044608 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1230048 | William R Bowen | Gen-Probe Incorporated 10210 Genetic Center Drive San Diego CA 92121 | Senior Vp, General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-02-23 | 20,000 | $42.50 | 37,825 | No | 4 | M | Direct | |
Common Stock | Disposition | 2011-02-23 | 20,000 | $61.96 | 17,825 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2011-02-23 | 20,000 | $0.00 | 20,000 | $42.50 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
3,265 | 2015-10-17 | No | 4 | M | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $61.75 to $62.25 The price reported above reflects the weighted average sale price for these transactions. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the reported transactions were effected.
- The stock option vested and became fully exercisable as of October 17, 2009.